Antonucci R, Porcella A, Pilloni MD. Perinatal asphyxia in the term newborn. J Pediatr Neonatal Individ Med. 2014;3(2):1–14. Ahearne CE. Short and long term prognosis in perinatal asphyxia: An update. World J Clin Pediatr. 2016;5(1):67. Gillam-Krakauer M, Gowen J, Clarence W. Birth Asphyxia. StatPearls. 2017. Jacobs SE, Hunt R, Tarnow-Mordi WO, Inder TE, Davis PG. Cooling for newborns with hypoxic ischaemic encephalopathy. Evidence-Based Child Heal A Cochrane Rev J. 2010;5(1):474–531. Azzopardi D, Strohm B, Marlow N, Brocklehurst P, Deierl A, Eddama O, et al. Effects of hypothermia for perinatal asphyxia on childhood outcomes. Obstet Gynecol Surv. 2014;69(11):639–41. Fattuoni C, Palmas F, Noto A, Fanos V, Barberini L. Perinatal asphyxia: A review from a metabolomics perspective. Molecules. 2015;20(4):7000–16. Shankaran S, Pappas A, McDonald SA, Vohr BR, Hintz SR, Yolton K, et al. Childhood outcomes after hypothermia for neonatal encephalopathy. N Engl J Med. 2012;366:2085–92. Pappas A, Shankaran S, McDonald SA, Vohr BR, Hintz SR, Ehrenkranz RA, et al. Cognitive Outcomes After Neonatal Encephalopathy. Pediatrics. 2015;135(3):624– 34. Solevåg AL, Nakstad B. Neuroprotective treatment for perinatal asphyxia. Tidsskr Nor Legeforen nr. 2012;132(21):2396–9. Benavente-fernández I, Synnes A, Grunau RE, Chau V, Ramraj C, Glass T. Association of Socioeconomic Status and Brain Injury With Neurodevelopmental Outcomes of Very Preterm Children. JAMA Netw. 2019;2(5):1–15. Chapman DA, Scott KG, Mason CA. Early Risk Factors for Mental Retardation : Role of Maternal Age and Maternal Education. Am J Ment Retard. 2002;107(1):46–59. Chin-lun G, Hahn J, Alamiri B, Buka SL, Goldstein JM, Laird N, et al. Socioeconomic disadvantage and neural development from infancy through early childhood. Int J Epidemiol. 2015;44(6):1889–99. Chaske R, Espinosa E, Galvis C, Gómez H, Ruiz LM, Toledo D, et al. Alteraciones en el neurodesarrollo en preescolares con antecedente de prematurez: un estudio de corte. Rev Med. 2019;26(1):45–54. DANE. Boletín Técnico Pobreza Multidimensional en Colombia Pobreza multidimensional en Colombia. Dane [Internet]. 2019;24. Ruiz J gabriel, Romero R, Buitrago A. Guía de practica clínica del recién nacido con asfixia perinatal. Minist Salud y Protección Soc. 2013;(07):11. Maoulainine FMR, Elbaz M, Elfaiq S, Boufrioua G, Elalouani FZ, Barkane M, et al. Therapeutic Hypothermia in Asphyxiated Neonates: Experience from Neonatal Intensive Care Unit of University Hospital of Marrakech. Int J Pediatr. 2017;2017:1– 7. Miller SP, Newton N, Ferriero DM, Partridge JC, Glidden D V., Barnwell A, et al. Predictors of 30-month outcome after perinatal depression: Role of proton MRS and socioeconomic factors. Pediatr Res. 2002;52(1):71–7. Benavente-fernández I, Siddiqi A, Miller SP. Socioeconomic status and brain injury in children born preterm: modifying neurodevelopmental outcome. Pediatr Res. 2019;5. Torres-muñoz J, Rojas C, Mendoza-urbano D, Marín-cuero D, Orobio S, Echandía C. Risk factors associated with the development of perinatal asphyxia in neonates at the. Biomedica. 2017;37:51–6. Martínez-Biarge M, Blanco D, García-Alix A, Salas S. Seguimiento de los recién nacidos con encefalopatía hipóxico-isquémica. An Pediatr. 2014;81(1). Davis-kean PE. The Influence of Parent Education and Family Income on Child Achievement: The Indirect Role of Parental Expectations and the Home Environment. J Fam Psychol. 2005;19(2):294–304. Hackman DA, Meaney MJ. Socioeconomic status and the brain: mechanistic insights from human and animal research. Nat Rev Neurosci. 2011;11(9):651–9. Adolph G, Troncoso G, Solano JM, Piñeros MC, Lengua MF, Benitez DC.Lineamiento técnico para el manejo de la asfixia perinatal. Secretaria distrital de salud. 2015. Koutra K, Chatzi L, Roumeliotaki T, Vassilaki M, Giannakopoulou E, Batsos C, et al. Socio-demographic determinants of infant neurodevelopment at 18 months of age: Mother–Child Cohort (Rhea Study) in Crete, Greece. Infant Behav Dev. 2012;35(1):48–59. Rodelo EA. Desempeño psicomotor en un grupo de niños de estratos sociales bajos en la ciudad de Barranquilla, 2012-2013. Biociencias [Internet]. 2016;8(2):55–60. Rainaldi MA, Perlman JM. Pathophysiology of Birth Asphyxia. Clin Perinatol. 2016;43(3):409–22. Torres J, Rojas C. Asfixia perinatal. Soc Colomb Pediatría. 2011;9:17–27. Jary S, Smit E, Liu X, Cowan FM, Thoresen M. Less severe cerebral palsy outcomes in infants treated with therapeutic hypothermia. Acta Paediatr. 2015;104(12):1241–7. Chalak LF. Perinatal Asphyxia in the Delivery Room: Initial Management and Current Cooling Guidelines. Neoreviews. 2016;17(8):463–70. Silveira RC, Procianoy RS. Hypothermia therapy for newborns with hypoxic ischemic encephalopathy. J Pediatr (Rio J). 2015;91(6):78–83. Sebetseba KN, Ramdin T, Ballot D. The Use of Therapeutic Hypothermia in Neonates with Perinatal Asphyxia at Charlotte Maxeke Johannesburg Academic Hospital: A Retrospective Review. Ther Hypothermia Temp Manag. 2017;00(00):1–6. Hoque N, Chakkarapani E, Liu X, Thoresen M. A Comparison of Cooling Methods Used in Therapeutic Hypothermia for Perinatal Asphyxia. Pediatrics. 2010;126(1):124-e130. Papile L-A, Baley JE, Benitz W. Hypothermia and Neonatal Encephalopathy. Pediatrics. 2014;133(6):1146–50. Astrid Celis L. Hipotermia terapéutica en asfixia perinatal. Precop. 2013;12(2):38–49. Edwards AD, Brocklehurst P, Gunn AJ, Halliday H, Juszczak E, Levene M, et al. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: Synthesis and meta-analysis of trial data. BMJ. 2010;340(7743):409. Alarcon Parraga, CL; Camargo Abello, M; Castro Rojas A. Estrategia de atención integral a la primera infancia: Fundamentos políticos, técnicos y de gestión. Pres la República-Cero a Siempre, Bogotá. 2013;282. Moreno Luna S, Granados Rugeles, C; Rodríguez Malagón, N;Gómez Restrepo C. Escala Abreviada de Desarrollo 3. Presidencia de la República. Alva M, Pilar M, Kahn C, Huerta M, Sánchez L, Calixto M, et al. Neurodesarrollo infantil: características normales y signos de alarma en el niño menor de cinco años. Rev Peru Med Exp Salud Publica. 2015;32(3):565–73. V. Alvarez; S. Guzmán CM. Análisis de Situación de Salud (ASIS) Colombia, 2016. Dirección de Epidemiología y Demografía, Ministerio de Salud y Protección Social. 2016. p. 1–163. Maoulainine F, Elbaz M, Elfaiq S, Boufrioua G, Elalouani FZ, Barkane M, et al. Therapeutic Hypothermia in Asphyxiated Neonates: Experience from Neonatal Intensive Care Unit of University Hospital of Marrakech. Int J Pediatr. 2017;3674140. Vázquez Baquero J. Clasificación Internacional del Funcionamiento, de la Discapaciadad y de la Salud: CIF, 2001. Organización Mundial de la Salud, Organización Panamericana de la Salud. 2001. p. 1–258. To T, Guttmann A, Dick PT, Rosenfield JD, Parkin PC, Tassoudji M, et al. Risk markers for poor developmental attainment in young children: Results from a longitudinal national survey. Arch Pediatr Adolesc Med. 2004;158(7):643–9. Simpson GA, Colpe L, Greenspan S. Measuring functional developmental delay in infants and young children: Prevalence rates from the NHIS-D. Paediatr Perinat Epidemiol. 2003;17(1):68–80. Velez Van Meerbeke A, Talero-Gutierrez C, Gonzalez-Reyes R. Prevalence of delayed neurodevelopment in children from Bogotá, Colombia, South America. Neuroepidemiology. 2007;29(1–2):74–7. Boletín 5, Discapacidad en la primera infancia: una realidad incierta en Colombia. Presidencia de la República-de Cero a Siempre. 2013. p. 32. Dauncey MJ, Bicknell RJ. Nutrition and neurodevelopment: mechanisms of developmental dysfunction and disease in later life. Nutr Res Rev. 1999;12(2):231– 53. Krebs NF, Lozoff B, Georgieff MK. Neurodevelopment: The impact of nutrition and inflammation during infancy in low-resource settings. Pediatrics. 2017;139(April):S50–8. Dwivedi D, Singh S, Singh J, Bajaj N, Singh HP. Neurodevelopmental Status of Children aged 6-30 months with Severe Acute Malnutrition. Indian Pediatr. 2018;55(2):131–3. Manrique FP, Correa MG, Moreno DM, Rocha VV. La lactancia materna y su relación con el neurodesarrollo. Pediatria (Santiago) [Internet]. 2014;47(1–2):22–30. Available from: http://dx.doi.org/10.1016/S0120-4912(15)30128-2 Repositorio EdocUR-U. Rosario Universidad del Rosario instacron:Universidad del Rosario
Kurinczuk JJ, White-Koning M BN. Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev Jun. 2010;86(6):329–38. Prevention CC for DC and. CDC Grand Rounds: public health approaches to reducing U.S. infant mortality. MMWR MorbMortal Wkly Rep. 2013;62(31):628–28. V. Alvarez; S. Guzmán CM. Análisis de Situación de Salud (ASIS) Colombia, 2016. Dir Epidemiol y Demogr Minist Salud y Protección Soc. :1–163. Ahearne CE. Short and long term prognosis in perinatal asphyxia: An update. World J Clin Pediatr. 2016;5(1):67. Al. RV et. Systematic Review of Biomarkers of Brain Injury in Term Neonatal Encephalopathy. Pediatr Neurol. 2009;40:215–26. Salud. OOM de la. Estadísticas Sanitarias Mundiales 2013: Una Mina de Información sobre Salud Publica. 2013 Social EM protección. Analisis de la situación de salud Colombia ASIS. Minist Protección Soc. 2015 Mir I CL. Serum Biomarkers to evaluate the integrity of the neurovascular unit. Early Hum Dev. 2009;90(10):707–11. Jacon J. KM et al. Etiologies of NICY deaths. Pediatrics. 2015;135(1):776–8. Sarnat HB SM. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol. 1976;33:696–705. Ennen CS, Huisman TA, Savage WJ, Northington FJ, Jennings JM, Everett AD et al. Glial fibrillary acidic protein as a biomarker for neonatal hypoxic-ischemic encephalopathy treated with whole-body cooling. Am J Obs Gynecol. 2011;205(3):251–7. Barkovich AJ, Miller SP, Bartha A et al. MRimaging,MRspectroscopy, and diffusion tensor imaging of sequential studies in neonates with encephalopathy. AJNR Am J Neuroradiol. 2006;27:533-47. Ramaswamy V, Horton J, Vandermeer B, Buscemi N, Miller S YJ. Systematic reviewof biomarkers of brain injury in term neonatal encephalopathy. Pediatr NeurolMar. 2009;40(3):215–26. Shankaran S, Laptook AR, Ehrenkranz RA et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2005;353:1574–84. Savman K, Blennow M, Gustafson K, Tarkowski E HH. Cytokine response incerebrospinal fluid after birth asphyxia. Pedia Res Jun. 1998;43(6):746–51. Imran N CL. Serum Biomarkers to evaluate the integrity of the neurovascular unit. Ear Hum Devel. 2014;90(10):707–11. Mir IN, Steven Brown L, Rosenfeld CR CL. Placental clearance/synthesis of neurobiomarkers GFAP and UCH-L1 in healthy term neonates and those with moderate-severe neonatal encephalopathy. Pediatr Res. 2019 Douglas-Escobar M, Yang C, Bennett J, Shuster J, Theriaque D, Leibovici A et al. A pilot study of novel biomarkers in neonates with hypoxic-ischemic encephalopathy. Pediatr Res Dec. 2010;68(6):531–6. Celtik C, Acunas B, Oner N PO. Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy. Brain Dev. 2004;26(6):398–402. Thornberg E, Thiringer K, Hagberg H KI. Neuron specific enolase in asphyxiated newborns: association with encephalopathy and cerebral function monitor trace. Arch Dis Child Fetal Neonatal. 1995;72:39–42. Gazzolo D, Marinoni E, Di Iorio R, Bruschettini M, Kornacka M, Lituania M et al. Urinary S100B protein measurements: A tool for the early identification of hypoxic-ischemic encephalopathy in asphyxiated full-term infants. Crit Care Med Jan. 2004;32(1):131–6. Risso FM, Serpero LD, Zimmermann LJ, GavilanesAW, Frulio R, Michetti F et al. Urine S100 BB and A1B dimers are valuable predictors of adverse outcome in full-term asphyxiated infants. Acta Paediatr. 2013;102(10):e467-72. Hu J, Ferreira A VEL. S100b induces neuronal death through nitric oxide reléase from astrocytes. J Neurochem. 1997;69:2294–301. Murray DM. Biomarkers in neonatal hypoxic-ischemic encephalopathy-Review of the literature to date and future directions for research. hand clin neurol. 2019;162:281–93. Sistema General de Seguridad Social en Salud M de S y de la PS. Republica de Colombia. Resolucion 8430 de 1993. Republica Ministerio de Salud. 1993. p. 1–19. Welch V, Petticrew M, Tugwell P, Moher D, Neill JO, Waters E, et al. Extensión PRISMA-Equidad 2012 : guías para la escritura y la publicación de revisiones sistemáticas enfocadas en la equidad en salud *. Rev Panam Salud Pública. 2013;34(4):60–8. Bersani I, Ferrari F, Lugli L, Ivani G, Conio A, Moataza B, Aboulgar H, Mufeed H, Iskander I, Kornacka M, Gruzfeld D, Dotta A, Savarese I CN et al. Monitoring the effectiveness of hypothermia in perinatal asphyxia infants by urinary S100B levels. Clin Chem Lab Med. 2019 Massaro AN1, Wu YW, Bammler TK, Comstock B, Mathur A, McKinstry RC, Chang T, Mayock DE MS et al. Plasma Biomarkers of Brain Injury in Neonatal Hypoxic-Ischemic Encephalopathy. J Pediatr. 2018 Alshweki A, Pérez-Muñuzuri A, López-Suárez O, Baña A CM. Relevance of urinary S100B protein levels as a short-term prognostic biomarker in asphyxiated infants treated with hypothermia. Med. 2017 Zaigham M, Lundberg F OP. Protein S100B in umbilical cord blood as a potential biomarker of hypoxic-ischemic encephalopathy in asphyxiated newborns. Early Hum Dev. 2017 Gazzolo D, Pluchinotta F, Bashir M, Aboulgar H, Said HM, Iman I, Ivani G, Conio A, Tina LG NF. Neurological abnormalities in full-term asphyxiated newborns and salivary S100B testing: the “Cooperative Multitask against Brain Injury of Neonates” (CoMBINe) international study. PLoS One. 2015 Chaparro-Huerta V, Flores-Soto ME, Merin Sigala ME, Barrera de León JC, Lemus-Varela ML, Torres-Mendoza BM B-ZC. Proinflammatory Cytokines, Enolase and S-100 as Early Biochemical Indicators of Hypoxic-Ischemic Encephalopathy Following Perinatal Asphyxia in Newborns. Pediatr Neonatol. 2017 Arca G, Arnaez J, Agut T, Núñez C, Stephan-Otto C, Valls A G-AA. Neuron-specific enolase is correlated with lesion topology, relative infarct volume and outcome of symptomatic NAIS. Arch Dis Child Fetal Neonatal Ed. 2020 JuanArnaezPhD CME-P ;Thais A. Neuron-Specific Enolase in Cerebrospinal Fluid Predicts Brain Injury After Sudden Unexpected Postnatal Collapse. Pediatr Neurol. 2019 Leifsdottir K1, 2, Mehmet H3, 4, Eksborg S1 HE. Fas-ligand and interleukin-6 in the cerebrospinal fluid are early predictors of hypoxic-ischemic encephalopathy and long-term outcomes after birth asphyxia in term infants. J Neuroinflammation. 2018 Patil UP, Mally PV WE. Serum biomarkers of neuronal injury in newborns evaluated for selective head cooling: a comparative pilot study. J Perinat Med. 2018 Ann-Marie Looney, Caroline Ahearne, Geraldine B. Boylan and DMM. Glial Fibrillary Acidic Protein Is Not an Early Marker of Injury in Perinatal Asphyxia and Hypoxic–Ischemic Encephalopathy. Front Neurol. 2015 Looney AM, O’Sullivan MP, Ahearne CE, Finder M, Felderhoff-Mueser, Boylan GB, Hallberg B MD. Altered Expression of Umbilical Cord Blood Levels of miR-181b and Its Downstream Target mUCH-L1 in Infants with Moderate and Severe Neonatal Hypoxic-Ischaemic Encephalopathy. Mol Neurobiol. Kelen D, Andorka C, Szabó M1, Alafuzoff A Kaila K SM. Serum copeptin and neuron specific enolase are markers of neonatal distress and long-term neurodevelopmental outcome. PLoS One. CE A. Short and long term prognosis in perinatal asphyxia: An update. World J Clin Pediatr. 2016;5(1):67. Ahearne CE, Chang RY, Walsh BH, Boylan GB MD. Cord Blood IL-16 Is Associated with 3-Year Neurodevelopmental Outcomes in Perinatal Asphyxia. Dev Neurosci. 2017 Orrock JE, Panchapakesan K, Vezina G, Chang T, Harris K, Wang Y, Knoblach S MA. Association of brain injury and neonatal cytokine response during therapeutic hypothermia in newborns with hypoxic-ischemic encephalopathy. Pediatr Res. 2016 González-Losada, Cristóbal; Dorta-Contreras AJ. Marcadores moleculares de la asfixia perinatal / Molecular markers of perinatal asphyxia. Rev Cuba pediatr. 2018 Chalak Lina. Inflammatory Biomarkers Of Bith Asphyxia. Clin Perinatol. 2016; 43:501-510 Murray Dm. Biomarkers in neonatal hypoxic-ischemic encephalopathy-Review of the literature to date and future directions for research. Handb Clin Neurol. 2019;162:281-293. González-Losada, Cristóbal; Dorta-Contreras, Alberto Juan. Marcadores moleculares de la asfixia perinatal / Molecular markers of perinatal asphyxia. Rev. cuba. Pediatr. 2018;90 (1) Fisher P. In search of biomarkers for HIE. J. Pediatr. 2018: 194 (3). Massaro A, Wu Y, Bammler T, Comstock B. Plasma Biomarkers Of Brain Injury in Neonatal Hypoyc –Ischemic Encephalopaty. J. Pediatric;2018: 194 (68) Repositorio EdocUR-U. Rosario Universidad del Rosario instacron:Universidad del Rosario
Agudelo DB. Neumonía complicada en pediatría, su manejo : un reto. Neumol Pediatr. 2013;8(2):79–85 Repositorio EdocUR-U. Rosario Universidad del Rosario instacron:Universidad del Rosario
Yisahak SF, Beagley J, Hambleton IR, Narayan KMV, Diabetes IDF. Diabetes in North America and The Caribbean : An update. Diabetes Res Clin Pract. 2013;103(2):223–30. Me C, Jefferies C, Dabelea D, Balde N, Seth A, Acerini CC, et al. Pediatric Diabetes ISPAD Clinical Practice Consensus Guidelines 2014 Compendium Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2014;15(20):4–17. Maahs DM, West NA, Lawrence JM, Mayer-davis EJ. Chapter 1 : Epidemiology of Type 1 Diabetes. Endocrinol Metab Clin North Am. 2011;39(3):481–97. da Rocha Fernandes J, Ogurtsova K, Linnenkamp U, Guariguata L, Seuring T, Zhang P, et al. IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes. Diabetes Res Clin Pract. 2016;117:48–54. Mirsadraee R, Khajedaluee M, Vakili R, Hasanabade A. Factors Associated with Newly Diagnosed Children with Diabetic Ketoacidosis. 2017;5(1):1–8. Rewers A, Chase HP, Mackenzie T, Walravens P, Roback M, Rewers M, et al. Predictors of acute complications in children with type 1 diabetes. JAMA. 2002;287(19):2511–8. Lebenthal Y, Shalitin S, Yackobovitch-Gavan M, Phillip M, Lazar L. Retrospective comparative analysis of metabolic control and early complications in familial and sporadic type 1 diabetes patients. J Diabetes Complications. 2012;26(3):219–24. Dabelea D, Rewers A, Stafford JM, Standiford DA, Lawrence JM, Saydah S, et al. Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study. Pediatrics. 2014;133(4):e938-45. SP L, ME J, AJ S, AC B, Gatling W. Psychosocial and socioeconomic risk factors for premature death in young people with type 1 diabetes. Diabetes Care. 2005;28(7):1618–1623 6p. Abdul-Rasoul M, Habib H, Al-Khouly M. “The honeymoon phase” in children with type 1 diabetes mellitus: Frequency, duration, and influential factors. Pediatr Diabetes. 2006;7(2):101–7 Hamman RF, Bell RA, Dabelea D, D’Agostino RB, Dolan L, Imperatore G, et al. The SEARCH for diabetes in youth study: Rationale, findings, and future directions. Diabetes Care. 2014;37(12):3336–44. Lawrence SE, Cummings E a, Gaboury I, Daneman D. Population-based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis. J Pediatr. 2005;146(5):688–92. Usher-Smith JA, Thompson M, Ercole A, Walter FM. Variation between countries in the frequency of diabetic ketoacidosis at first presentation of type 1 diabetes in children: A systematic review. Diabetologia. 2012;55(11):2878–94. Jefferies CA, Nakhla M, Derraik JGB, Gunn AJ, Daneman D, Cutfield WS. Preventing Diabetic Ketoacidosis. Pediatr Clin North Am. 2015;62(4):857–71. Jessup AB, Grimley MB, Meyer E, Gregory P, Belger A, Hoffman WH, et al. Effects of Diabetic Ketoacidosis on Visual and Verbal Neurocognitive Function in Young Patients Presenting with New-Onset Type 1 Diabetes. J Clin Res Pediatr Endocrinol. 2015;7(May 2013):203–10. Coll M, Durán P, Parra LM. Guía de diagnóstico y manejo de diabetes mellitus tipo 1. Minist la Protección Soc. 2007;333–60. Gregory JM, Moore DJ, Simmons JH. Type 1 Diabetes Mellitus. Pediatr Rev. 2013;34(5):203–15. Dorman JS, Laporte RE. Enormous variation by place and ethnic group. 1998;21(4):525–9. Schober E. Regional differences and temporal incidence trend of Type I diabetes mellitus in Austria from 1989 to 1999: A nationwide study. Diabetologia. 2000;43(11):1449–50. Rosenbauer J, Herzig P, Von Kries R, Neu A, Giani G. Temporal, seasonal, and geographical incidence patterns of Type I diabetes mellitus in children under 5 years of age in Germany. Diabetologia. 1999;42(9):1055–9. Aschner P. Diabetología. 2016;95–100. Ministerio De Salud. Guia De Atencion De La Obesidad. 2013;14. Van Belle T, Coppieters K, Von Herrath M. Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies. Physiol Rev. 2011;91:79–118. Of S, Carediabetes M. STANDARDS OF MEDICAL CARE Standards of Medical Care in Diabetes d 2016. 2016;39(January). American Diabetes Association. Standards of Medical Care in Diabetes. 2016;39(January). Cooke DW, Plotnick L. Management of diabetic ketoacidosis in children and adolescents. Pediatr Rev. 2008;29(12):431–435; quiz 436. Klingensmith GJ, Tamborlane W V., Wood J, Haller MJ, Silverstein J, Cengiz E, et al. Diabetic ketoacidosis at diabetes onset: Still an all too common threat in youth. J Pediatr. 2013;162(2):330–334.e1. Rewers A, Klingensmith G, Davis C, Petitti DB, Pihoker C, Rodriguez B, et al. Presence of diabetic ketoacidosis at diagnosis of diabetes mellitus in youth: The search for diabetes in youth study. Pediatrics. 2008;121(5):E1258–66. Wolfsdorf JI, Allgrove J, Craig ME, Edge J, Glaser N, Jain V, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2014;15 Suppl 2:154–79. J Wolfsdorf, MB, BCH, Nicole Glaser, MD and Mark A. Sperling M. Diabetic Ketoacidosis in Infants, Children, and Adolescents A consensus statement from the American Diabetes Association. Scottish Med J August 1, 2015 60121-125. 2006 Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335–43. Smith CP. Diabetic ketoacidosis. Curr Paediatr. 2006;16(2):111–6. Agus MSD, Wolfsdorf JI. Diabetic Ketoacidosis in Children. Pediatr Clin North Am. 2005 Aug;52(4):1147–63. Briscoe VJ. Hypoglycemia in Type 1 and Type 2 Diabetes: Physiology, Pathophysiology, and Management. Clin Diabetes. 2006;24(3):115–21. Wherrett D, Huot C, Mitchell B, Pacaud D. Type 1 Diabetes in Children and Adolescents. Can J Diabetes. 2013;37(SUPPL.1):S153–62. McCrimmon RJ, Sherwin RS. Hypoglycemia in type 1 diabetes. Diabetes. 2010;59(10):2333–9. Cryer PE. Hypoglycemia in Type 1 Diabetes Mellitus. Endocrinol Metab Clin North Am. 2010 Sep;39(3):641–54. Ly TT, Maahs DM, Rewers A, Dunger D, Oduwole A, Jones TW. Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2014;15(S20):180–92. Rewers MJ, Pillay K, de Beaufort C, Craig ME, Hanas R, Acerini CL, et al. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes. 2014;15(SUPPL.20):102–14. Cato MA, Mauras N, Mazaika P, Kollman C, Cheng P, Aye T, et al. Longitudinal Evaluation of Cognitive Functioning in Young Children with Type 1 Diabetes over 18 Months. J Int Neuropsychol Soc. 2016;22(3):293–302. Blasetti A, Chiuri RM, Tocco AM, Giulio CD, Mattei PA, Ballone E, et al. The Effect of Recurrent Severe Hypoglycemia on Cognitive Performance in Children With Type 1 Diabetes: A Meta-analysis. J Child Neurol. 2011;26(11):1383–91. DCCT Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes. 1997;46(2):271–86. Delamater AM, Albrecth DR, Postellon DC GJ. Racial differences in metabolic control of children and adolescents with type I diabetes mellitus. Diabetes Care. 1991;20:714–20. Szypowska A, Skórka A. The risk factors of ketoacidosis in children with newly diagnosed type 1 diabetes mellitus. Pediatr Diabetes. 2011;12(4 PART 1):302–6. Dunger DB, Sperling M a, Acerini CL, Bohn DJ, Daneman D, Danne TP a, et al. European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society consensus statement on diabetic ketoacidosis in children and adolescents. Pediatrics. 2004;113(2):e133–40. Fritsch M, Rosenbauer J, Schober E, Neu A, Placzek K, Holl RW. Predictors of diabetic ketoacidosis in children and adolescents with type 1 diabetes. Experience from a large multicentre database. Pediatr Diabetes. 2011;12(4 PART 1):307–12. Bismuth E, Laffel L. Can we prevent diabetic ketoacidosis in children? Pediatr Diabetes. 2007;8(SUPPL. 6):24–33. Adi S, Gerard-Gonzalez A. Type 1 Diabetes Mellitus. Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome. 2018;:3-13. Aschner P. Epidemiología de la diabetes en Colombia. Av en Diabetol. 2010;26(2):95–100. Chiang JL, Maahs DM, Garvey KC, Hood KK, Laffel LM, Weinzimer SA, et al. Type 1 diabetes in children and adolescents: A position statement by the American Diabetes Association. Diabetes Care. 2018;41(7):1–19. Del Villar-Guerra P, De Luis-Román D, González-Sagrado M, Del Villar-Galán R. Descripción de las características de la cetoacidosis diabética al inicio en una muestra de pacientes con diabetes mellitus tipo 1. Med Clin (Barc). 2015;144(6):280–1. Oyenusi EE, Nwaogu NTL, Oduwole AO. Keto-acidosis at diagnosis of type 1 diabetes in children and adolescents in Lagos, South-West Nigeria: the pattern over 10 years. Orig Artic 12 African J Diabetes Med. 2016;24(2). Oyarzabal Irigoyen M, Garcia Cuartero B, Barrio Castellanos R, Torres Lacruz M, Gomez Gila AL, Gonzalez Casado I, et al. Ketoacidosis at onset of type 1 diabetes mellitus in pediatric age in Spain and review of the literature. Pediatr Endocrinol Rev. 2012 Mar;9(3):669–71. He P, Chen G, Wang Z, Guo C, Zheng X. The role of parental education in child disability in China from 1987 to 2006. PLoS One. 2017;12(10):1–10. Zuckerman-Levin N, Dabaja-Younis H, Ameer E, Cohen M, Maor Y, Shehadeh N. Effect of Socioeconomic Status and Ethnicity on Glycemic Control in Arab and Jewish Youth with Type 1 Diabetes Mellitus. Rambam Maimonides Med J. 2018;9(4):1–8. Chou S, Liu J, Grossman M, Joyce TJ. Parental Education and Child Health : Statistics (Ber). 2007;2:213–50. Repositorio EdocUR-U. Rosario Universidad del Rosario instacron:Universidad del Rosario
Rho J., Ahn C., Gao A., el al. Disparities in Mortality of Hipsanic Cystic Fibrosis Patients in the United States: A national and regional Cohort study. Am J Respir Crit Care Med.2018 May 9. Catalina Vasquez, Ricardo Aristizabal WD. Fibrosis Quistica en Colombia. http://www.neumologia-pediatrica.cl Restrepo-Gualteros SM, Navarro SM, Muñoz AM, Quevedo JP. Complicaciones pulmonares en fibrosis quística. Repert Med y Cirugía. 2016;25(1):22–32 Rodríguez-acevedo A, Morales O, Durango H, Pineda-trujillo N. Análisis de isonimia en una muestra de padres de pacientes antioqueños con fibrosis quística. Biomedica. 2012;31:139–44 P??rez MM, Luna MC, Pivetta OH, Keyeux G. CFTR gene analysis in Latin American CF patients: Heterogeneous origin and distribution of mutations across the continent. J Cyst Fibros. 2007;6(3):194–208 Geborek A, Hjelte L. Association between genotype and pulmonary phenotype in cystic fibrosis patients with severe mutations. J Cyst Fibros. European Cystic Fibrosis Society.; 2011;10(3):187–92 Mickle JE, Cutting GR. Genotype-phenotype relationships in cystic fibrosis. Med Clin North Am. 2000;84(3):597–607. McKone EF, Emerson SS, Edwards KL, Aitken ML. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet (London, England). 2003;361(9370):1671–6 Davies JC, Ebdon A-M, Orchard C. Recent advances in the management of cystic fibrosis. Arch Dis Child. 2014;(Mcc):1–4 Dorfman R, Sandford A, Taylor C, Huang B, Frangolias D, Wang Y, et al. Complex two-gene modulation of lung disease severity in children with cystic fibrosis. J Clin Invest. 2008;118(3):1040–9. Restrepo CM, Pineda L, Rojas-Martínez A, Gutiérrez CA, Morales A, Gómez Y, et al. CFTR mutations in three Latin American countries. Am J Med Genet. 2000;91(4):277–9 Ortigosa L. Fibrosis quistica. Aspectos diagnosticos. Colomb Med. 2007;38(SUPPL. 1):41–9 Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N, et al. Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation. J Pediatr. Elsevier Inc.; 2017;181:S4–S15.e1 Lucarelli M, Bruno S, Pierandrei S, Ferraguti G. A Genotypic-Oriented View of Genetics Highlights Specific Mutational Patterns Underlying Clinical Macrocategories of Cystic Fibrosis. Mol Med. 2015;21(1):257–71 Jay LM, Mateus H, Fonseca D, Restrepo CM, Keyeux G. PCR-heterodúplex por agrupamiento: Implementación de un método de identificación de portadores de la mutación más común causal de fibrosis quística en Colombia. Colomb Med. 2006;37(3):176–82 Cutting GR. Cystic fibrosis genetics: from molecular understanding to clinical application. Nat Rev Genet. Nature Publishing Group; 2015;16(1):45–56 Spoonhower KA, Davis PB. Epidemiology of Cystic Fibrosis. Clin Chest Med. Elsevier Inc; 2016;37(1):1–8 Shastri SS, Kabra M, Kabra SK, Pandey RM, Menon PSN. Characterisation of mutations and genotype-phenotype correlation in cystic fibrosis: Experience from India. J Cyst Fibros. 2008;7(2):110–5 Egan ME. Genetics of Cystic Fibrosis. Clin Chest Med. 2016;37(1):9–16 Longo DL, Stoltz D a, Meyerholz DK, Welsh MJ. Origins of Cystic Fibrosis Lung Disease. N Engl J Med. 2015;372(4):351–62. Restrepo CM, Pineda L, Rojas-Martínez A, Gutiérrez CA, Morales A, Gómez Y, et al. CFTR mutations in three Latin American countries. Am J Med Genet. 2000;91(4):277–9. Salcedo Posadas A, García Novo MD. Tratado de Fibrosis Quística. Praxis Pharmaceutical; 2012. 1-551 p DANE. Nacimientos y Defunciones Cifras preliminares 2014-2015. 2015 Keyeux G, Sánchez D, Garavito P, Stand I, Rodas C, Bienvenu T, et al. Estudios moleculares en pacientes colombianos con fibrosis quística. 1997;22:167–7 Keyeux G, Rodas C, Bienvenu T, Garavito P, Vidaud D, Sanchez D, et al. CFTR mutations in patients from Colombia: implications for local and regional molecular diagnosis programs. Hum Mutat. 2003;22(July):259 Brewington J, Clancy JP. Diagnostic Testing in Cystic Fibrosis. Clin Chest Med. Elsevier Inc; 2016;37(1):31–46 Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008;153(2):S4–14 Vasquez C, Ricardo A, Daza W. Fibrosis quística en Colombia. Neum Pediat. 2010;5(1):44–5 Vasquez C, Colmenares A. Guía de Práctica Clínica Fibrosis Quística. Ministerio de Protección social; 2014. 729 p Paranjape SM, Mogayzel Jr PJ. Cystic Fibrosis. Pediatr Rev. 2014;35(5):194–204 Repositorio EdocUR-U. Rosario Universidad del Rosario instacron:Universidad del Rosario
Ojeda G, Ordoñez M, Ochoa L. Encuesta nacional de demografía y salud 2010-ENDS [Internet]. Profamilia. 2011. Disponible en: http://www.sidalc.net/cgi-bin/wxis.exe/?IsisScript=MIAGRO.xis&method=post&formato=2&cantidad=1&expresion=mfn=009075\nhttp://scholar.google.com/scholar?hl=en&btnG=Search&q=intitle:Encuesta+nacional+de+demograf?a+y+salud+2010#0 Rudolph A. Medicine P. Atlas of the Newborn. Vol. 1. BC Decker Inc. Hamilton London. Kumar J, Upadhyay A, Dwivedi AK, Gothwal S, Jaiswal V, Aggarwal S. Effect of oil massage on growth in preterm neonates less than 1800 g: A randomized control trial. Indian J Pediatr. 2013;80(6):465–9. Rodríguez SR, Ribera CG De, Garcia MPA. El recién nacido prematuro. El recién nacido Prematuro. 2008;68–77. Field T, Diego M H-RM. Potential underlying mechanisms for greater weight gain in massaged preterm infants. Infant Behav Dev. Neu J. Necrotizing enterocolitis: The mystery goes on. Neonatology. 2014;106(4):289–95. Kim JH. Necrotizing enterocolitis: The road to zero. Semin Fetal Neonatal Med [Internet]. Elsevier Ltd; 2014;19(1):39–44. Disponible en:: http://dx.doi.org/10.1016/j.siny.2013.10.001 Leslie. Hipoglicemia neonatal. SOBESTIANSKY J BARCELLOS, DESN Doença dos. 2007;38–49. Disponible en Eberhard R, Meneghello J, Gajardo R. Enfermedad hemolítica del recién nacido. Rev Chil pediatría. 1947;18(5). Holme N, Chetcuti P. The pathophysiology of respiratory distress syndrome in neonates. Paediatr Child Heal (United Kingdom) [Internet]. Elsevier Ltd; 2012;22(12):507–12. Disponible en:: http://dx.doi.org/10.1016/j.paed.2012.09.001 Lancet T, Black R, Bloomberg JH. El Nacimiento Prematuro es Ahora la Principal Causa de Muerte en Niños Pequeños. 2013;2014:1–10. Marin Gabril M, Martin Moreiras J, Lliteras Freixas G, Delgado Gallego S, Pallas Alonso C, De la Cruz Bértolo J, et al. Valoración del test de Ballard en la determinación de la edad gestacional | Anales de Pediatría. An Pediatr [Internet]. 2006;64(2):140–5. Disponible en:: http://zl.elsevier.es/es/revista/anales-pediatria-37/valoracion-test-ballard-determinacion-edad-gestacional-13084173-originales-2006 Iñiguez F, Sánchez I. Desarrollo pulmonar. Neumol pediátrica. 2008;3(2):148–55. Disponible en:: http://xa.yimg.com/kq/groups/15444044/1902322035/name/DesarrolloPulmonar.pdf Davis RP, Mychaliska GB. Neonatal pulmonary physiology. Semin Pediatr Surg. Elsevier; 2013;22(4):179–84. Disponible en:: http://dx.doi.org/10.1053/j.sempedsurg.2013.10.005 McMenamin JB. Intraventricular haemorrhage in the newborn: current concepts. Ir Med J. 1984;77(7):213–5. Bolisetty S, Dhawan A, Abdel-Latif M, Bajuk B, Stack J, Lui K. Intraventricular hemorrhage and neurodevelopmental outcomes in extreme preterm infants. Pediatrics. 2014;133(1):55–62. Ballabh P. Intraventricular Hemorrhage in Premature Infants: Mechanism of Disease. NIH Public Access. Pediatr Res. 2010;67(1):1–8. Camba Longueira F, Perapoch Lopez J, Martin Begue N. Retinopatia De La Prematuridad. Protoc Diagnóstico Ter la AEP Neonatol [Internet]. 2008;443–7. Disponible en:: www.aeped.es/protocolos American sunflower association. 2010. Sunflower Oil. Asagir· Asoc argentina girasol. Oil S. Asagir· asociación argentina de girasol. Asagir· Asoc argentina girasol. Albert a. Schneiter E. Sunflower technology and production. Am Soc Agron. no. 35. Kulkarni A, Kaushik JS, Gupta P, Sharma H, Agrawal RK. Massage and touch therapy in neonates: The current evidence. Indian Pediatr. 2010;47(9):771–6. Field T, Diego M, Hernandez-Reif M. Moderate pressure is essential for massage therapy effects. Int J Neurosci. 2010;120(5):381–5. Field TM. Massage therapy effects. Am Psychol. 1998;53(12):1270–81. Sankaranarayanan K, Mondkar J, Chauhan M, Mascarenhas B, Mainkar A, Salvi R. Oil massage in neonates: An open randomized controlled study of coconut versus mineral oil. Indian Pediatr. 2005;42(9):877–84. Vaivre-Douret L, Oriot D, Blossier P, Py A, Kasolter-P??r?? M, Zwang J. The effect of multimodal stimulation and cutaneous application of vegetable oils on neonatal development in preterm infants: A randomized controlled trial. Child Care Health Dev. 2009;35(1):96–105. Dabi DR, Arora V, Mohan P, Kothari U, Dashora T. XXth Annual Convention of National Neonatology Forum, Mumbai, 3-5 November, 2000. Lineamientos Teoricos para la implementacion de programas madre canguro en colombia. Ministerio de salud. 2009. Darmstadt GL1, Ahmed S, Ahmed AS, Saha SK. Mechanism for prevention of infection in preterm neonates by topical emollients: a randomized, controlled clinical trial,Pediatr Infect Dis J. 2014 Nov;33. The effects of massage therapy in hospitalized preterm neonates: A systematic review.María José Álvarez cols, International Journal of Nursing Studies, Volume 69, 2017. Repositorio EdocUR-U. Rosario Universidad del Rosario instacron:Universidad del Rosario